Yapay Zeka Hızlı Bakış & Çıkarımlar
AI InsightIts effectiveness is expressed inhigher clinical and pathological complete response rates and safety with the same rates of acute toxicity.
📌 3 Maddede Bu Makale
Abstract
Background/aim: The present study aimed to examine whether the combination of neoadjuvant volumetric modulated arc radiotherapy(VMAT) using simultaneous integrated boost (SIB-VMAT) techniques and chemotherapy with capecitabine is associated with better clinicaland dosimetric outcomes compared to the standard treatment.Materials and methods: The study included 59 patients with cT2–T4 rectal cancer. In the standard arm, patients (n = 37) were treatedpreoperatively with image-guided VMAT plus capecitabine. In the SIB arm, patients (n = 22) were treated with the SIB-VMAT techniqueplus capecitabine. All patients underwent radical surgical resection after neoadjuvant radiochemotherapy.Results: In the standard arm, cT0N0 was reached in 12 patients (32.4%), primary tumor clinical downstaging was observed in 22 patients(59.5%), and disease stability was achieved in 3 patients (8.1%). In the SIB arm, cT0N0 was reached in 15 patients (68.2%), primary tumorclinical downstaging was observed in 6 patients (27.3%), and disease stability was achieved in 1 patient (4.5%) (P = 0.028). Completepathological response was observed in 11 patients (29.7%) in the standard arm and in 13 patients (59.1%) in the SIB arm (P = 0.026). In theSIB arm mild diarrhea appeared in 59.1%, moderate in 40.9%, and severe in 0% of the cases. In the standard arm mild, moderate, and severediarrhea rates were in 54.1%, 43.2%, and 2.7%, respectively. In the SIB arm mild, moderate, and severe cystitis appeared in 63.6%, 22.7%,and 13.6%, while in the standard group mild cystitis developed in 67.6%, moderate in 24.3%, and severe in 8.1%. Mild, moderate, and severeradiation dermatitis rates were 45.5%, 45.5%, and 9.1% in the SIB group and 40.5%, 48.6%, and 10.8% in the standard group, respectively.Conclusion: The SIB-VMAT technique is effective and safe for irradiating locally advanced rectal cancer. Its effectiveness is expressed inhigher clinical and pathological complete response rates and safety with the same rates of acute toxicity.